From all these considerations, the challenge to discover new CCR5 and CXCR4 antagonists is of paramount importance to improve the therapeutic armamentarium against HIV infection, and the possibility to develop dual co-receptor antagonists appears particularly appealing. The gene discussed is CXCR4; the disease is HIV infectious disease.